John M. Maraganore
2018
In 2018, John M. Maraganore earned a total compensation of $5.1M as Chief Executive Officer (principal executive officer at Alnylam Pharmaceuticals, a 259% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $480,000 |
|---|---|
| Option Awards | $3,782,231 |
| Salary | $800,000 |
| Other | $27,038 |
| Total | $5,089,269 |
Maraganore received $3.8M in option awards, accounting for 74% of the total pay in 2018.
Maraganore also received $480K in non-equity incentive plan, $800K in salary and $27K in other compensation.
Rankings
In 2018, John M. Maraganore's compensation ranked 1,964th out of 14,244 executives tracked by ExecPay. In other words, Maraganore earned more than 86.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,964 out of 14,244 | 86th |
Division Manufacturing | 710 out of 5,765 | 88th |
Major group Chemicals And Allied Products | 235 out of 2,128 | 89th |
Industry group Drugs | 187 out of 1,817 | 90th |
Industry Pharmaceutical Preparations | 145 out of 1,391 | 90th |
Source: SEC filing on April 2, 2021.
Maraganore's colleagues
We found four more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2018.